Zugmaier, G <br/><br/>
Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia.  [electronic resource] 

 -  Blood cancer journal  Sep 2014 
 - 244 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2014.64  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bispecific--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoglobulins--blood<br/>Male<br/>Neoplasm, Residual<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--blood